<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/50/3529" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/50/3529/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/50/3529/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_3529"><akn:num>3529</akn:num><akn:heading>Medical advisory board</akn:heading><akn:content><akn:p>§ 3529. Medical advisory board(a) EstablishmentThe Director shall establish within the Agency a medical advisory board (in this section referred to as the “Board”).


(b) DutiesThe Board shall—(1) conduct a study on the Office of Medical Services of the Agency, and submit reports regarding such study, in accordance with subsection (c); and

(2) upon request, provide advice and guidance in connection with any independent review of the Office conducted by an inspector general.


(c) Study(1) ObjectivesIn conducting the study under subsection (b)(1), the Board shall seek to—(A) contribute to the modernization and reform of the Office of Medical Services;

(B) ensure that the activities of the Office are of the highest professional quality; and

(C) ensure that all medical care provided by the Office is provided in accordance with the highest professional medical standards.


(2) ReportsThe Board shall submit to the congressional intelligence committees, in writing—(A) interim reports on the study; and

(B) a final report on the study, which shall—(i) set forth in detail the findings of the study and the recommendations of the Board, based on such findings and taking into consideration the objectives under paragraph (1), regarding any changes to the activities of the Office of Medical Services; and

(ii) include, as applicable, any additional or dissenting views submitted by a member of the Board.




(d) Membership(1) Number and appointmentThe Board shall be composed of 9 members, appointed as follows:(A) 1 member appointed by the Speaker of the House of Representatives.

(B) 1 member appointed by the minority leader of the House of Representatives.

(C) 1 member appointed by the majority leader of the Senate.

(D) 1 member appointed by the minority leader of the Senate.

(E) 1 member appointed by the Chairman of the Permanent Select Committee on Intelligence of the House of Representatives.

(F) 1 member appointed by the ranking minority member of the Permanent Select</akn:p></akn:content><akn:subsection eId="subsec_3529_a"><akn:num>(a)</akn:num><akn:heading>Establishment</akn:heading><akn:content><akn:p>(a) Establishment The Director shall establish within the Agency a medical advisory board (in this section referred to as the “Board”).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_b"><akn:num>(b)</akn:num><akn:heading>Duties</akn:heading><akn:content><akn:p>(b) Duties The Board shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_c"><akn:num>(c)</akn:num><akn:heading>Study</akn:heading><akn:content><akn:p>(c) Study</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_d"><akn:num>(d)</akn:num><akn:heading>Membership</akn:heading><akn:content><akn:p>(d) Membership</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_e"><akn:num>(e)</akn:num><akn:heading>Meetings</akn:heading><akn:content><akn:p>(e) Meetings</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_f"><akn:num>(f)</akn:num><akn:heading>Information access</akn:heading><akn:content><akn:p>(f) Information access</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_g"><akn:num>(g)</akn:num><akn:heading>Termination</akn:heading><akn:content><akn:p>(g) Termination The Board shall terminate on the date that is 5 years after the date of the first meeting of the Board.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_3529_h"><akn:num>(h)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(h) Definitions In this section, the terms “congressional intelligence committees” and “intelligence community” have the meanings given such terms in section 3003 of this title.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>